01Dec
Covid–19 coronavirus: global merger review
Merger review processes are being impacted worldwide as merger control authorities adapt to take account of the consequences of Covid-19 coronavirus. While critical transactions are likely to be reviewed, as far as possible, in accordance with normal practice, many cases may face changes in approach and practice (eg extensions of timelines in certain circumstances). See our overview for an indication of the different approaches being taken by authorities around the world. Please see full...
By:
Allen & Overy LLP
Related
News of an outbreak of a new coronavirus first identified in Wuhan, Hubei Province, China raises iss...
Read More >
As the end of the year approaches, there are several legal considerations and tasks that businesses ...
Read More >
The Small Business Administration (SBA) has designated COVID-19 as a qualifying event for the provis...
Read More >
Alternative Technical Concepts (ATCs) are an important tool that government agencies use, and privat...
Read More >
In Vision Pharma, LLC v. Sunrise Pharmaceutical, Inc., No. 2:13-cv-04692, 2018 WL 3085213 (D.N.J. Ju...
Read More >
Although there have only been a handful of confirmed cases of the 2019 Novel Coronavirus (2019-nCoV ...
Read More >